Growth Business

SEPTEMBER 13, 2023

Indeed, tech start-ups in London alone raised a record $26bn (£19bn) in funding in 2021, more than double the total in 2020. However, the reality is that many venture capital investors are playing it cautious, wanting to invest in later, safer funding rounds for companies with proven revenue. It has raised over $1bn for 18 funds.

Capital 52

Capital Business Funds Investment 52

Mergers and Inquisitions

NOVEMBER 1, 2023

The short answer to #1 is that healthcare private equity firms operate in specific verticals with stable-ish cash flows, such as healthcare services, nursing facilities, medical devices, equipment, and healthcare IT. Are there many private healthcare companies for PE firms to acquire? to consolidate their market power in specific regions.

Private Equity 59

Private Equity Healthcare Equities Middle Market 59

Cooley M&A

JANUARY 25, 2023

But it wasn’t all carve outs and concerned investors – even with the headwinds in the industry and beyond, there were still several traditional public M&A deals involving biotechnology or medical device companies, as large pharmaceutical companies continued to have cash to deploy for acquisitions. Let’s dig in.

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Collaboration 40

Cooley M&A

JANUARY 23, 2024

Strained access to public markets and funding The IPO market remained relatively inactive in 2023, leading many life sciences companies looking to raise funds to turn to other exit strategies. Buyers likely will continue to focus on companies with commercialized products or later-stage development products for M&A.

M&A 52

M&A Mergers and Acquisitions Pharmaceutical Acquisitions 52

Cooley M&A

JANUARY 20, 2022

A notable example was a consortium of PE funds agreeing to acquire a majority stake in Medline for $34 billion. In November, Johnson & Johnson announced that it will split itself into two publicly traded companies , separating its pharmaceutical and medical devices businesses from its consumer products business. time highs in 2021.

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Mergers 40

Cooley M&A

JANUARY 25, 2023

Going further, rather than arranging upfront committed debt financing, Thoma Bravo opted to fund the purchase price for its announced $2.3 Looking forward, we should expect even more enforcement as the agencies continue to execute the Biden administration’s mandate for increased enforcement and receive additional funding for that mission.

M&A 52

M&A Mergers and Acquisitions Private Equity Mergers 52

Mergers and Inquisitions

MARCH 5, 2025

If you had to pick a single industry that could be interesting to every hedge fund investing in individual companies, it might be biotech. Of course, biotech is not an official hedge fund strategy. Example Biotech Trades What Makes Biotech Hedge Funds Different? also find their way into the industry. And What Do They Do?

Funds 64

Funds Healthcare Mergers and Acquisitions Valuation 64